Pharma IQ | 11/26/2010
Dr. Paul Matejtschuk Principal Scientist at NIBSC, joins Andrea Charles from Pharma IQ, to address the key challenges in optimal formulation development and how advances in freeze drying have impacted on formulation development. Matejtschuk also dicusses how can we utilise accelerated degradation studies to better predict product stability and what methods are the industry are employing to accelerate lyophilisation cycle development.
To continue reading this story Click Here
RECOMMENDED
Pharma Contract Manufacturing 2025
2025-03-03
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More